InfuSystems (INFU) vs OraSure Technologies (OSUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InfuSystems (INFU) has outperformed OraSure Technologies (OSUR) over the past year, gaining 31.1% versus a gain of 17.1%. Over five years, INFU leads with a +3.6% price change compared with -63.9% for OSUR. InfuSystems is the larger company by market cap ($267.1 million vs $261.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INFU | OSUR |
|---|---|---|
| Share price | $13.41 | $3.80 |
| Market cap | $267.09M | $261.74M |
| 1-day change | +0.60% | +1.74% |
| YTD return | +48.61% | +56.82% |
| 1-year return | +31.07% | +17.13% |
| 5-year return | +3.57% | -63.89% |
| P/E ratio (TTM) | 33.52 | — |
| Forward P/E | 25.79 | — |
| EPS (TTM) | $0.40 | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.85 | $4.58 |
| 52-week low | $7.29 | $2.08 |
| Distance from 52-week high | -3.18% | -17.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +25.50% | +5.40% |
| Average volume | 139.81K | 480.26K |
| Shares outstanding | 19.92M | 68.97M |
| Employees | 461 | 500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INFU has outperformed OSUR by 13.9 percentage points over the past year.
About InfuSystems
INFU stock →InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.
Health Care · Medical/Dental Instruments · 461 employees
About OraSure Technologies
OSUR stock →OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Health Care · Medical/Dental Instruments · 500 employees
INFU vs OSUR FAQ
Which is bigger, InfuSystems or OraSure Technologies?
InfuSystems (INFU) is larger, with a market capitalization of $267.09M compared with $261.74M for OraSure Technologies (OSUR).
Which stock has performed better over the past year, INFU or OSUR?
INFU returned +31.07% over the past 12 months, compared with +17.13% for OSUR (price return, excluding dividends). Past performance does not predict future results.
Are InfuSystems and OraSure Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.